Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Braintree Laboratories

Braintree Laboratories
1982 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer and manufacturer of specialty pharmaceuticals in gastroenterology. The company has four prescription product lines in the US market in two therapeutic categories - colon cleansing preparations and a gastro esophageal reflux disease treatment.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 60 Columbian Street West
  • PO Box 850929
  • Braintree, MA 02185
  • United States

+1 (800) 000-0000

Braintree Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Braintree Laboratories‘s full profile, request access.

Request full access to PitchBook

Braintree Laboratories Executive Team (1)

Name Title Board
Seat
Contact
Info
Harry Keegan IV Chief Executive Officer